Sep 25, 2015

Amgen is at it Again - Sues Hospira For Not Wanting to Dance Over its Biosimilar

On September 18, 2015, Amgen Inc. (Amgen) sued Hospira Inc. (Hospira) in the U.S. District Court for the District of Delaware for allegedly violating the information sharing and advance-notice provisions of the Biologics Price Competition and Innovation Act of 2009 (BPCIA) as well as for infringement of U.S. Patent Nos. 5,856,298 and 5,756,349. In December 2014, […]
back to top